Leo M - Search Results

1

Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: effect of individual dose tailoring.

Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, Pigliaru F, Mariotti S. Mercuro G, et al. Among authors: leo m. J Clin Endocrinol Metab. 2000 Jan;85(1):159-64. doi: 10.1210/jcem.85.1.6298. J Clin Endocrinol Metab. 2000. PMID: 10634380 Clinical Trial.

2

[The effect of nifedipine on arterial pressure and exercise tolerance in hypertensive patients].

Seguro C, Sau F, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A. Seguro C, et al. Among authors: leo mr. Cardiologia. 1992 Aug;37(8):547-53. Cardiologia. 1992. PMID: 1486575 Italian.

3

[Hemodynamic assessment at rest and during dynamic physical exercise in young subjects with and without hypertensive parents].

Seguro C, Sau F, Zedda N, Mura O, Montaldo C, Scano G, Arru A, Leo MR, Aru A, Cherchi A. Seguro C, et al. Among authors: leo mr. Cardiologia. 1995 Jun;40(6):391-7. Cardiologia. 1995. PMID: 8640851 Italian.

4

[The effect of nifedipine in hypertensive cardiopathy. An echocardiographic and electrocardiographic study].

Sau F, Seguro C, Lai C, Onnis E, Orani E, Soro A, Leo MR, Cherchi A. Sau F, et al. Among authors: leo mr. Cardiologia. 1993 Jun;38(6):369-76. Cardiologia. 1993. PMID: 8402746 Clinical Trial. Italian.

5

Asymmetry indicates more severe and active disease in Graves' orbitopathy: results from a prospective cross-sectional multicentre study.

Perros P, Žarković MP, Panagiotou GC, Azzolini C, Ayvaz G, Baldeschi L, Bartalena L, Boschi AM, Nardi M, Brix TH, Covelli D, Daumerie C, Eckstein AK, Fichter N, Ćirić S, Hegedüs L, Kahaly GJ, Konuk O, Lareida JJ, Okosieme OE, Leo M, Mathiopoulou L, Clarke L, Menconi F, Morris DS, Orgiazzi J, Pitz S, Salvi M, Muller I, Knežević M, Wiersinga WM, Currò N, Dayan CM, Marcocci C, Marinò M, Möller L, Pearce SH, Törüner F, Bernard M; European Group on Graves’ Orbitopathy. Perros P, et al. Among authors: leo m. J Endocrinol Invest. 2020 Dec;43(12):1717-1722. doi: 10.1007/s40618-020-01258-w. Epub 2020 May 30. J Endocrinol Invest. 2020. PMID: 32474767 Free PMC article.

6

Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy.

Sisti E, Menconi F, Leo M, Profilo MA, Mautone T, Mazzi B, Rocchi R, Latrofa F, Nardi M, Vitti P, Marcocci C, Marinò M. Sisti E, et al. Among authors: leo m. J Endocrinol Invest. 2015 Jun;38(6):661-8. doi: 10.1007/s40618-015-0241-7. Epub 2015 Jan 18. J Endocrinol Invest. 2015. PMID: 25596664

7

Total thyroid ablation in Graves' orbitopathy.

Menconi F, Leo M, Vitti P, Marcocci C, Marinò M. Menconi F, et al. Among authors: leo m. J Endocrinol Invest. 2015 Aug;38(8):809-15. doi: 10.1007/s40618-015-0255-1. Epub 2015 Mar 5. J Endocrinol Invest. 2015. PMID: 25740065 Review.

8

Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway.

Lisi S, Botta R, Rotondo Dottore G, Leo M, Latrofa F, Vitti P, Marinò M. Lisi S, et al. Among authors: leo m. J Endocrinol Invest. 2016 Sep;39(9):1039-44. doi: 10.1007/s40618-016-0464-2. Epub 2016 Apr 19. J Endocrinol Invest. 2016. PMID: 27094046

9

Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.

Sabini E, Sisti E, Coco B, Leo M, Ionni I, Menconi F, Profilo MA, Mazzi B, Rocchi R, Latrofa F, Vitti P, Brunetto M, Marcocci C, Marinò M. Sabini E, et al. Among authors: leo m. J Endocrinol Invest. 2016 Nov;39(11):1323-1327. doi: 10.1007/s40618-016-0518-5. Epub 2016 Jul 27. J Endocrinol Invest. 2016. PMID: 27465669

10

Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial.

Leo M, Bartalena L, Rotondo Dottore G, Piantanida E, Premoli P, Ionni I, Di Cera M, Masiello E, Sassi L, Tanda ML, Latrofa F, Vitti P, Marcocci C, Marinò M. Leo M, et al. J Endocrinol Invest. 2017 Mar;40(3):281-287. doi: 10.1007/s40618-016-0559-9. Epub 2016 Oct 12. J Endocrinol Invest. 2017. PMID: 27734319 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

948 results

Search Page